alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>



                                                                   Exhibit 10.74

                                 ALLONGE TO NOTE
                             (LOAN NO. 0001969-001)

         THIS ALLONGE is made as of the 1st day of May, 1999, by and between
HEALTHCARE IMAGING SERVICES, INC., a Delaware corporation ("BORROWER") and DVI
FINANCIAL SERVICES INC., a Delaware corporation ("LENDER").

BACKGROUND

         A. Borrower is duly and justly indebted to Lender under a certain Note
dated September 30, 1998, to be effective October 1, 1998, given by Borrower to
Lender in the original principal amount of $14,000,000.00 (the "NOTE").

         B. At Borrower's request, Lender has agreed to modify certain terms of
the Note in accordance with the terms of this Allonge.

         NOW, THEREFORE, the parties hereto, intending to legally bound, agree
as follows:

         1. MATURITY DATE. As used in the Note, the term "Maturity Date" shall
hereafter refer to August 1, 1999.

         2. EFFECT OF ALLONGE. All term and conditions of this Allonge not
expressly modified hereby shall remain in full force and effect and are hereby
ratified and confirmed by the parties hereto. To the extent of any inconsistency
between the terms and conditions of this Allonge and the Note, the terms of this
Allonge shall prevail.

         3. GOVERNING LAW. This Allonge is governed by the laws of the
Commonwealth of Pennsylvania (without giving effect to any principles of
conflicts of law).

         IN WITNESS WHEREOF, the parties hereto have executed this Allonge as of
the date first above written.


HEALTHCARE IMAGING SERVICES INC.    DVI FINANCIAL SERVICES INC.

By: /s/Elliott H. Vernon            By: /s/Gerald A. Hayes, Jr.
------------------------------      ------------------------------
Name: Elliott H. Vernon             Name: Gerald A. Hayes, Jr.
Title: Chairman/CEO                 Title: Vice President Chief Credit Officer

                                       22
Exhibit  32.1











CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of Par Pharmaceutical Companies, Inc. (the Company) for the quarterly period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Patrick G. LePore, Chairman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



(1)

The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



This certification accompanies the Report and shall not be deemed filed with the Securities and Exchange Commission and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933 or Securities Exchange Act of 1934 (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.







/s/ Patrick G. LePore

Patrick G. LePore

Chairman, President and Chief Executive Officer

May 5, 2011
**EXHIBIT 31.1****CERTIFICATION**I, Michael R. Gorsage, the Chief Executive Officer of Technology Solutions Company, certifythat:1. I have reviewed this quarterly report on Form 10-Q of Technology Solutions Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a. designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  b. evaluated the effectiveness of the registrant’s disclosure controls and procedures, andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on suchevaluation; and  c. disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): a. all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  b. any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.       Date: November 14, 2005 By: /s/ MICHAEL R. GORSAGE       Michael R. Gorsage      Chief Executive Officer
Before the First Division,

March 10, 1955

No. 58809.

protest 244069-K (New York).

#### I. B. Cohen & Sons Corp. *v.*United States,

Opinion by

Oliver, C. J.

In accordance with stipulation of counsel that the merchandise consists of compass rings similar in all material respects to those the subject of Abstract 58039, the claim of the plaintiff was sustained.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          43,131
<SECURITIES>                                    19,034
<RECEIVABLES>                                   27,778
<ALLOWANCES>                                     2,699
<INVENTORY>                                          0
<CURRENT-ASSETS>                               113,538
<PP&E>                                          17,760
<DEPRECIATION>                                  14,404
<TOTAL-ASSETS>                                 124,198
<CURRENT-LIABILITIES>                           36,438
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           441
<OTHER-SE>                                      87,319
<TOTAL-LIABILITY-AND-EQUITY>                   124,198
<SALES>                                              0
<TOTAL-REVENUES>                                33,182
<CGS>                                                0
<TOTAL-COSTS>                                   37,215
<OTHER-EXPENSES>                               (1,124)
<LOSS-PROVISION>                                   323
<INTEREST-EXPENSE>                                   8
<INCOME-PRETAX>                                (3,240)
<INCOME-TAX>                                   (1,299)
<INCOME-CONTINUING>                            (1,941)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,941)
<EPS-BASIC>                                   (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>
June 14, 1965

No. 69387.

#### New York Merchandise Co., Inc. *v.*United States,

protest 61/24786.

C.D. 2533. Plaintiff’s application for rehearing granted.
<PAGE>   1

                                                                    EXHIBIT 11.1


                           AMERICA SERVICE GROUP INC.

                      (IN THOUSANDS, EXCEPT PER SHARE DATA)


<TABLE>
<CAPTION>
                                                                NINE MONTHS ENDED                   QUARTER ENDED
                                                                  SEPTEMBER 30,                     SEPTEMBER 30,
                                                             -----------------------            ---------------------
                                                             1999               1998            1999             1998
                                                             ----               ----            ----             ----
<S>                                                          <C>              <C>             <C>               <C>
Net income                                                   $  851           $ 4,045         $ 1,220           $1,585
Preferred stock dividends                                       ---               ---              97              ---
                                                        -------------------------------------------------------------------
                                                                                                                   ---
Numerator for basic earnings per share - income
   available to common stock holders                         $  851           $ 4,045         $ 1,317           $1,585
                                                        ===================================================================

Denominator for basic earnings per share - weighted
   average shares                                             3,588             3,550           3,613            3,564

Effect of dilutive securities                                   ---               113           1,173               90
                                                        -------------------------------------------------------------------

Weighted average common shares outstanding - diluted
                                                              3,588             3,663           4,786            3,662
                                                        ===================================================================

Basic earnings per share                                     $ 0.24           $  1.14         $  0.34           $ 0.44
                                                        ===================================================================
Diluted earnings per share                                   $ 0.24           $  1.10         $  0.28           $ 0.43
                                                        ===================================================================
</TABLE>
# L_2023195EN.01005301.xml

| 3.8.2023 | EN | Official Journal of the European Union | L 195/53 |
| --- | --- | --- | --- |

3.8.2023

EN

Official Journal of the European Union

L 195/53

---

Corrigendum to the Guideline (EU) 2022/747 of the European Central Bank of 5 May 2022 amending Guideline 2012/120/EU on the statistical reporting requirements of the European Central Bank in the field of external statistics (ECB/2011/23) (ECB/2022/23)

(
  Official Journal of the European Union L 137 of 16 May 2022
  )

On the second cover page, in the title:

for:

‘
  Guideline (EU) 2022/747 of the European Central Bank of 5 May 2022 amending Guideline 2012/120/EU on the statistical reporting requirements of the European Central Bank in the field of external statistics (ECB/2011/23) (ECB/2022/23)

  ’,

read:

‘
  Guideline (EU) 2022/747 of the European Central Bank of 5 May 2022 amending Guideline ECB/2011/23 on the statistical reporting requirements of the European Central Bank in the field of external statistics (ECB/2022/23)

  ’;

on page 177, in the title:

for:

‘
  GUIDELINE (EU) 2022/747 OF THE EUROPEAN CENTRAL BANK

of 5 May 2022

amending Guideline 2012/120/EU on the statistical reporting requirements of the European Central Bank in the field of external statistics (ECB/2011/23) (ECB/2022/23)

  ’,

read:

‘
  GUIDELINE (EU) 2022/747 OF THE EUROPEAN CENTRAL BANK

of 5 May 2022

amending Guideline ECB/2011/23 on the statistical reporting requirements of the European Central Bank in the field of external statistics (ECB/2022/23)

  ’.

---
Consulting Agreement





EXHIBIT 4.27

Consulting Agreement

Between:

Robert Tomjlenovic;

And

Global Precision Medical Inc. ("Global")

WHEREAS Robert Tomjlenovic has financial contacts in the United States
that are potential sources of capital for the Company in its ongoing operations,
Global hereby enters into a limited consulting agreement whereby in return for
arranging meetings and introductions, Tomjlenovic, on a case by case basis at
the sole discretion of Global, will be compensated in the following manner:


  	Telephone expenses.

 
	Travel expenses in the event that Tomjlenovic is required to accompany
    representatives of Global to meetings arranged by him.

 
	Finders fees on verifiable capital contributions to the treasury of the
    Company, such fees to be set by the Board of Directors of Global on a case
    by case basis and in accordance with various regulatory requirements.





Undertakings


Tomilenovic undertakes to represent himself as an independent consultant and
not an officer, director or employee of Global and will use only information
fully disclosed to the public in informing potential investors of the Company of
the merits of such an investment.

Agreed to this3rd day of October 2002 by:


/s/ Robert Tomjlenovic 

Robert Tomjlenovic



 





/s/  Lindsay Semple      

Lindsay Semple

CEO - GLOBAL PRECISION MEDICAL
**Steve Altomare Quality Aerial Photography**  **LLC**

**38317 Welsh Drive Prairieville, Louisiana 707**  **69** July 10 , 2015 US DEPARTMENT OF TRANSPORTATI ON Federal Aviation Administration 800 In dependence Avenue, SW Washington, DC 20591 Quality Aerial Photography LLC requesting exemptions and relief from the requirements of sections 14CFR: 61.113(a) &(b), 91.7(a), 91.121, 91.151(b), 91.405(a), 91.409(a) (1) &(a)(2), and 91.417(a) & (b). The exemptions pertain to commercial use and operation of two DJ I Inspire I Unmanned Aircraft S ys tems (UAS) in accordance with the FAA Modernization and Reform Act of 2012 / FAA Section 333 Exemption. Reason for seeking exemption :

- Use of UAS for commercial applications.

- Conduct business legally.

- Be in compliance with all FAA regulations and stipulations when flying our UAS. Request for ex emption(s) relating to the public benefit as a whole : UAS video/photography of real estate (commercial, residential and industrial), land survey s, land surveillance, industrial and commercial inspections, sporting events and special events over certain areas of these United States would be performed safel y, legally and economically. Accordingl y, minimal imp acts on the environment and a safer more economical avenue for businesses and individuals in need of these services can be achieved. Summary Quality Aerial Photography

LLC, pursuant to Section 333 of the FAA Modernization and Reform Act of 2012:

- Petitioning for exemption of sections 14CFR : 61.113(a) & (b), 91.7(a), 91.121, 91.151(b), 91.405(a), 91.409(a)(1) & (a)(2) and 91.417(a) & (b).

- Seek exemption(s) for commercial use of our two DJI Inspire UAS. Respectivel y submitted , Steve Altomare Quality Aerial Photography LLC
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----|-----------------------------------------------------------------------------------------------------------------------|

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ Todd H. Takeyasu                                                                                          |
|--------|---------------------------------------------------------------------------------------------------------------|
|   | Todd H. Takeyasu                                                                                              |
|   | Executive Vice President and Chief Financial Officer                            |
|   | of Penn West Petroleum Ltd., successor to Penn West Energy Trust |

----
Exhibit
10-a


 


FIRST AMENDMENT

OF

ADC TELECOMMUNICATIONS, INC. 401(K) EXCESS PLAN

(2002 Restatement)


 


WITNESSETH: 
That


 


WHEREAS, ADC TELECOMMUNICATIONS, INC., a Minnesota
corporation (the “Principal Sponsor”), by resolution of its Board of Directors,
has heretofore established and maintained a nonqualified, unfunded, deferred
compensation and supplemental retirement plan for the benefit of a select group
of management or highly compensated eligible employees, which in its most
restated form, is embodied in a document effective January 1, 2002 and entitled
“ADC Telecommunications, Inc. 401(k) Excess Plan (2002 Restatement)” (the
“Plan Statement”); and


 


WHEREAS, The Principal Sponsor has delegated to the
Retirement Committee of ADC Telecommunications, Inc. the power to make
further amendments of the Plan Statement in any respect that does not
materially increase the cost of the plan, and the Retirement Committee
desires  to amend the Plan Statement;


 


NOW, THEREFORE, The Plan Statement is hereby amended
in the following respects:


 


1.                 CODE § 162(m)
DELAY.  Effective for distributions
payable on or after February 26, 2002, Section 7 of the Plan Statement shall be
amended by the addition of the following new Section 7.5 and all subsequent
sections (and cross-references thereto) shall be renumbered:


 


7.5               Code §
162(m) Delay.  If the
Committee determines that delaying the time that initial payments are made or
commenced would increase the probability that such payments would be fully
deductible for federal or state income tax purposes, the Employer may
unilaterally delay the time of the making or commencement of payments until the
January 31 of the calendar year next following the calendar year in which the
payments would otherwise be payable.


 


2.                 SAVINGS
CLAUSE.  Save and except as hereinabove
expressly amended, the Plan Statement shall continue in full force and effect.
(Reap. Dec. 10592)

#### Leslie B. Canion, for a/c Enco Chemical Corporation *v.*United States

Entry Nos. 3720-H; 7204-H.

*400(Decided October 7, 1963)

*Eugene R. Piolcrell*for the plaintiff.

*John W. Douglas,*Assistant Attorney General, for the defendant.

Oliver, Chief Judge:

These two appeals for reappraisement are directed to the merchandise represented by the invoice items marked “A” and initialed “WFB,” which consists of sodium perborate, exported from West Germany during the period from January 3,1958, through June ll, 1958. Appraisement thereof was made on the basis of foreign value, as such value is defined in section 402(c) of the Tariff Act of 1930, as amended by the Customs Administrative Act of 1938 (74 Treas. Dec. 17, T.D. 49646).

Counsel for the respective parties have agreed that the merchandise in question and the issues involved herein are the same in all material respects as those which were the subject of decision in *United States*v. *Philipp Brothers Chemicals, Inc.,*46 Cust. Ct. 803, A.R.D. 134, the record in which case was incorporated herein by consent.

Following the cited decision, I find that the proper basis for ap-praisement of the merchandise in question, as hereinabove identified, is export value, as defined in section 402(d) of the Tariff Act of 1930, and hold that such statutory value therefor, as shown in counsel’s stipulation of submission, is as follows:

> Date of Exportation Value

> November 27, 1957 $29.00 per 100 kilos, less ocean freight and insurance

> May 19, 1958 $29.20 per 100 kilos, less ocean freight and insurance

Judgment will be rendered accordingly.
HCFC IFR

Lee, Amanda I. 

t

o

:

Luke Hall-Jordan 05/13/2011 04:48 PM

Cc: Drusilla Hufford, David Donaldson

State Department has no substantive comment. Thanks and have a good weekend.
PLATT & BUESCHER

DEFENDANT’S OBJECTION TO Attorneys at Law

TRIAL DATE/ROSENAU-1 P.O. Box 727

No. CR06-157MJP Coupeville, WA 98239

Phone: (360) 678-6777

Fax: (360) 678-0323

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

Chief Judge Marsha J. Pechman

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF WASHINGTON

AT SEATTLE

UNITED STATES OF AMERICA,

Plaintiff,

v.

HENRY ROSENAU

Defendant.

No. CR06-157MJP

DEFENDANT’S OBJECTION

TO TRIAL DATE

COMES NOW, HENRY ROSENAU, by and through his counsel of record, Craig A.

Platt, and hereby respectfully and formally objects to the current trial date.

The Defense respectfully objects to the current trial date of April 23, 2012. Further delay

will only serve to further prejudice the incarcerated defendant. Additionally, the Defense moves

this Court for an order setting the trial date to a time that complies with the law including but not

limited to the Sixth Amendment of the United States Constitution, 18 U.S.C §3161, 18 U.S.C.

§3162, and any other applicable law.

Case 2:06-cr-00157-MJP Document 82 Filed 03/08/12 Page 1 of 3
PLATT & BUESCHER

DEFENDANT’S OBJECTION TO Attorneys at Law

TRIAL DATE/ROSENAU-2 P.O. Box 727

No. CR06-157MJP Coupeville, WA 98239

Phone: (360) 678-6777

Fax: (360) 678-0323

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

Respectfully submitted this 8

th day of March, 2012.

PLATT & BUESCHER

s/Craig Platt_______________

Craig Platt

Attorney for Defendant

WSBA #12396

P.O. Box 727

Coupeville, Washington 98239-0727

Telephone: (360) 678-6777

Fax: (360) 678-0323

Email: craig@plattbuescher.com

Case 2:06-cr-00157-MJP Document 82 Filed 03/08/12 Page 2 of 3
PLATT & BUESCHER

DEFENDANT’S OBJECTION TO Attorneys at Law

TRIAL DATE/ROSENAU-3 P.O. Box 727

No. CR06-157MJP Coupeville, WA 98239

Phone: (360) 678-6777

Fax: (360) 678-0323

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

CERTIFICATE OF SERVICE

I hereby certify that on 3/8/2012, I electronically filed the foregoing with the Clerk of the

Court using the CM/ECF system which will send notification of such filing to the attorney(s) of

record for the Government.

s/Craig Platt_______________

Craig Platt

Attorney for Defendant

WSBA #12396

P.O. Box 727

Coupeville, Washington 98239-0727

Telephone: (360) 678-6777

Fax: (360) 678-0323

Email: craig@plattbuescher.com

Case 2:06-cr-00157-MJP Document 82 Filed 03/08/12 Page 3 of 3